- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01226433
Family Planning Through Dairy Cooperatives
Providing Family Planning Services Sustainably Through Dairy Cooperatives in Kenya
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Access to family planning and other reproductive health services remains difficult in much of rural Kenya. One option for improving rural access to family planning is to use existing community events outside of the health sector as platforms for delivering information and services. This study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these events, known as Field Days, a healthcare provider will have a tent in which Field Day attendees can receive basic family health services free of charge. The services offered will be: family planning counseling and methods, immunizations, antenatal care, screening and treatment for sexually transmitted infections, and HIV counseling and testing. Since the services are no different than those that could be obtained at Ministry of Health or some private facilities, the service provision is not considered to be part of the research.
Women receiving any service from the health care provider will be recruited for an interview that will measure their demand for family planning and attitudes about receiving services during the field day. In addition, the study will track the number of different types of services provided, the total number of Field Day attendees, and the cost of the service model. The study will be carried out at five Field Days in Rift Valley and Central provinces.
Participants will not be tested for STI/HIV as part of this research; however, at their request, they may have received a test from the provider prior to the research interview. At the time of consent, they will have already received the test, so the consent form will not include anything specific to testing. In Kenya, all STI/HIV test results are reported to the national public health authorities. These reports are not used for contacting patients but for planning purposes.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Rift Valley & Central
-
Various, Rift Valley & Central, Kenia
- 5 Community Outreach Events
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:females aged 18-49 receiving health services at a field day event -
Exclusion Criteria:
-
Studie plan
Hoe is de studie opgezet?
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Health Services Research
Tijdsspanne: 1 year
|
Unmet need for family planning among women attending Field Days aged 18-49
|
1 year
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Health Services Research
Tijdsspanne: 1 year
|
Interest in receiving health services through Field Day model
|
1 year
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: John Bratt, MPP, MA, FHI 360
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
- AE bijwerking
- AIDS verworven immunodeficiëntiesyndroom
- ALT (SGPT) alanineaminotransferase
- ART antiretrovirale therapie
- AST (SGOT) aspartaataminotransferase
- DCF-gegevensverzamelingsformulieren
- DMC Data Monitoring Comité
- FDA (VS) Food and Drug Administration
- GCP Good Clinical Practice-richtlijnen
- HB sAg Hepatitis B-oppervlakte-antigeen
- ICH Internationale Conferentie van Harmonisatie
- IND Onderzoek Nieuwe Drugsaanvraag
- IRB Institutionele Beoordelingsraad
- IU Internationale eenheden
- mg milligram(men)
- mm3 kubieke millimeter
- PCR-polymerase kettingreactie
- SAE ernstige bijwerking
- µg microgram
- ULN bovengrens van het normale bereik
- WB Western-blot
Andere studie-ID-nummers
- 10227
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .